Drs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.

Three dermatologists discuss the case of an 18-year-old patient with AD who is exploring nonsteroidal options to manage his disease.

Peter Lio, MD, clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss the importance of the skin barrier and its importance in acne treatment.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss how adherence becomes an issue in the treatment of acne and what factors lead to lack of adherence in patients.

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, define the terms associated with biosimilars, including the interchangeable designation.

An expert rheumatologist and dermatologist discuss differences between biosimilars and generic drugs.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses the 5 biggest cleansing mistakes.

Drs Noor and Bhatia have a conversation about cost and financial assistance from pharmaceutical companies.

Drs Bhatia and Lamb discuss the case of a 12-year-old child with asthma and how they would manage his disease.

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.

Joshua Zeichner, MD, and Raj Chovatiya, MD, PhD, dive deep into the pathogenesis of atopic dermatitis and discuss how agents treating atopic dermatitis work.

Joshua Zeichner, MD, and Vikash Oza, MD, discuss characteristics of type 2 inflammation and the impact of itching on pediatric patients with atopic dermatitis.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Josh Zeichner, MD, and discusses Jori Skincare.

Experts discuss the case of a 4-year-old girl with lighter skin and treatment options for a young child.

Three experts emphasize the importance of setting expectations for AD treatment with patients.

Susan Taylor, MD, FAAD, discusses how an individual can select a sunscreen as well as barriers to using them.